176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
9.86%
Revenue growth exceeding 1.5x MRVL's 5.85%. David Dodd would verify if faster growth reflects superior business model.
6.79%
Cost growth 1.1-1.25x MRVL's 5.58%. Bill Ackman would demand evidence of cost control initiatives.
14.93%
Gross profit growth exceeding 1.5x MRVL's 6.11%. David Dodd would verify competitive advantages.
4.61%
Margin expansion exceeding 1.5x MRVL's 0.25%. David Dodd would verify competitive advantages.
22.73%
R&D growth above 1.5x MRVL's 2.23%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
19.66%
Operating expenses growth above 1.5x MRVL's 5.68%. Michael Burry would check for inefficiency.
10.48%
Total costs growth above 1.5x MRVL's 5.62%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
41.18%
D&A growth while MRVL reduces D&A. John Neff would investigate differences.
11.01%
EBITDA growth exceeding 1.5x MRVL's 2.90%. David Dodd would verify competitive advantages.
4.15%
EBITDA margin growth while MRVL declines. John Neff would investigate advantages.
5.56%
Similar operating income growth to MRVL's 7.21%. Walter Schloss would investigate industry trends.
-3.92%
Operating margin decline while MRVL shows 1.29% growth. Joel Greenblatt would examine position.
-13.04%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
4.26%
Pre-tax income growth 50-75% of MRVL's 8.24%. Martin Whitman would scrutinize operations.
-5.10%
Pre-tax margin decline while MRVL shows 2.27% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
6.35%
Net income growth 50-75% of MRVL's 9.50%. Martin Whitman would scrutinize operations.
-3.19%
Net margin decline while MRVL shows 3.45% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.65%
Both companies reducing share counts. Martin Whitman would check patterns.
-5.51%
Both companies reducing diluted shares. Martin Whitman would check patterns.